Inhibrx Biosciences, Inc. (INBX) Earnings Per Share (EPS)
Inhibrx Biosciences, Inc. (INBX) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2020-12-31 | -$3.01 |
| 2021-12-31 | -$2.15 |
| 2022-12-31 | -$3.62 |
| 2023-12-31 | -$20.48 |
| 2024-12-31 | $114.01 |
| 2025-12-31 | -$9.04 |
How INBX compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| ATOS | Atossa Therapeutics Inc. | -$4.04 |
| RARE | Ultragenyx Pharmaceutical Inc. | -$5.83 |
| AGIO | Agios Pharmaceuticals Inc. | -$7.12 |
| NKTR | Nektar Therapeutics | -$9.73 |
| PRGO | Perrigo Company plc | -$10.29 |
These are five companies in the same sector as INBX with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Inhibrx Biosciences, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("INBX")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | INBX | $88.37 | +0.00% | 0.25M |
| 3 | ||||
| 4 | ||||
| 5 |